What the results showed About 9 out of every 10,000 people in the GLP-1 group were diagnosed with ischemic optic neuropathy over 18 months
They have a tremendous amount of excess skin, requiring multiple [skin-removal] surgeries. But the 50% losing far less weightmore like 20 to 30 poundsstill have skin laxity and volume changes in their faces, breasts, and bodies
The compound is designed for subcutaneous injection, typically administered in the abdomen, thigh, or upper arm, following the same injection site recommendations used for other GLP-1 agonists
If you are researching retatrutide, you likely have questions about how to access it, what the clinical evidence actually shows, how it compares to existing treatments, and what you should know before considering this therapy
Most obesity treatments have focused primarily on helping people consume fewer calories